Neuhaus Peter, Jonas Sven, Settmacher Utz, Thelen Armin, Benckert Christoph, Lopez-Hänninen Enrique, Hintze Rainer E
Klinik für Allgemein-, Viszeral und Transplantationschirurgie, Charité, Campus Virchow Klinikum, Humboldt University Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Langenbecks Arch Surg. 2003 Jul;388(3):194-200. doi: 10.1007/s00423-003-0383-5. Epub 2003 Jun 18.
Surgical resection provides the only chance of cure for patients suffering from hilar cholangiocarcinoma. Although appropriate procedures are not agreed upon, an increase in radicality has been observed during the past 20 years.
The literature as well as our own experience after 133 resections of hilar cholangiocarcinomas were reviewed.
Tumor-free margins represent the most important prognostic parameter. Hilar resections as least radical resective procedure will generate rates of formally curative resections of less than 50%. Even after these formally curative resections, long-term survival cannot be achieved. Only additional liver resections will increase the number of long-term survivors to significant figures. In our series, the best 5-year survival rate of 72% was achieved after right trisegmentectomy with concomitant resection of the portal vein bifurcation.
Right trisegmentectomy and combined portal vein resection represent the best way to comply with basic rules of surgical oncology for hilar cholangiocarcinoma. This procedure will provide the most pronounced benefit among various types of liver resection, whereas local resections of the extrahepatic bile duct must be considered as an oncologically inefficient procedure.
手术切除是肝门部胆管癌患者获得治愈的唯一机会。尽管对于合适的手术方式尚无定论,但在过去20年中,手术根治性有了提高。
回顾了相关文献以及我们自己在133例肝门部胆管癌切除术后的经验。
切缘无肿瘤是最重要的预后参数。肝门部切除作为最不彻底的切除手术,其根治性切除率不到50%。即使经过这些根治性切除,也无法实现长期生存。只有额外的肝切除才能使长期存活者数量显著增加。在我们的系列研究中,门静脉分叉部联合切除的右三叶切除术后5年生存率最高,达72%。
右三叶切除联合门静脉切除是符合肝门部胆管癌外科肿瘤学基本原则的最佳方法。该手术在各种肝切除类型中获益最为显著,而肝外胆管局部切除在肿瘤学上应被视为无效手术。